Israel
· Delayed Price · Currency is ILS · Price in ILAAllmed Solutions Statistics
Total Valuation
Allmed Solutions has a market cap or net worth of ILS 35.47 million. The enterprise value is -9.47 million.
| Market Cap | 35.47M |
| Enterprise Value | -9.47M |
Important Dates
The next estimated earnings date is Thursday, March 6, 2025.
| Earnings Date | Mar 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Allmed Solutions has 96.38 million shares outstanding. The number of shares has increased by 8.93% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 96.38M |
| Shares Change (YoY) | +8.93% |
| Shares Change (QoQ) | +1.74% |
| Owned by Insiders (%) | 20.61% |
| Owned by Institutions (%) | 10.01% |
| Float | 36.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.93 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.70 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1.23 |
Financial Position
The company has a current ratio of 19.17, with a Debt / Equity ratio of 0.02.
| Current Ratio | 19.17 |
| Quick Ratio | 19.17 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.09 |
| Interest Coverage | -9.85 |
Financial Efficiency
Return on equity (ROE) is -23.98% and return on invested capital (ROIC) is -24.57%.
| Return on Equity (ROE) | -23.98% |
| Return on Assets (ROA) | -23.65% |
| Return on Capital (ROIC) | -24.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -714,000 |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.16% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -3.16% |
| 50-Day Moving Average | 35.83 |
| 200-Day Moving Average | 38.03 |
| Relative Strength Index (RSI) | 51.87 |
| Average Volume (20 Days) | 65,749 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -22.55M |
| Pretax Income | -13.57M |
| Net Income | -13.57M |
| EBITDA | -22.37M |
| EBIT | -22.55M |
| Earnings Per Share (EPS) | -0.12 |
Balance Sheet
The company has 48.31 million in cash and 718,000 in debt, giving a net cash position of 47.59 million or 0.49 per share.
| Cash & Cash Equivalents | 48.31M |
| Total Debt | 718,000 |
| Net Cash | 47.59M |
| Net Cash Per Share | 0.49 |
| Equity (Book Value) | 47.27M |
| Book Value Per Share | 0.40 |
| Working Capital | 46.55M |
Cash Flow
In the last 12 months, operating cash flow was -7.65 million and capital expenditures -53,000, giving a free cash flow of -7.71 million.
| Operating Cash Flow | -7.65M |
| Capital Expenditures | -53,000 |
| Free Cash Flow | -7.71M |
| FCF Per Share | -0.08 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Allmed Solutions does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.93% |
| Shareholder Yield | -8.93% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
The last stock split was on February 22, 2015. It was a reverse split with a ratio of 0.05.
| Last Split Date | Feb 22, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |